Antimicrobial susceptibility and molecular characterization for some virulence factors of Proteus Mirabilis isolated from patients in Al-Qadisiyah Province/ Iraq

  • Najlaa Abdallah D. AL-Oqaili College of Biotechnology/University of Al-Qadisiyah, Iraq.
  • Majed Kadim AL-Shebli College of Education/University of Al-Qadisiyah, Iraq
  • Azhar N.H. Almousawi College of Pharmacy/ University of Al-Qadisiyah, Iraq.


Total of 64 Samples clinical isolates were collected from various sources included urine, ear external swab, wounds swab, burns swab, high cervical and endometrium cervical swab, which was taken from (in-patients) and (out-patients) in Maternal, and General Teaching Hospital in AL-Diwaniya city during the period from 1/3/2015 till 30/9/2015. The resistance of bacterial isolates to 12 different antibiotics was tested and isolates showed different resistance to anti-βata Lactam including penicillin and Amoxicillin/ Clavulanic acid by (100%), cefotaxime by (86%), and Cephalexin  by (90.62%), Imipenem by (18.75%), and Meropenem by (15.62%). Some of the virulence factors have been studied genetically (20 isolate), in terms of the genetic aspect, five genes were obtained for virulence factors and at varying rates, as the urease  enzyme ureC, fimbriae formation mrpA, flagella flaA, hemolysin enzyme hpmA and biofilm  formation luxS (60, 40,100, 45, 55) % , respectively.


1-Abbas KF, Al-Khafaji JK, Al-Shukri MS. Molecular Detection of some Virulence Genes in Proteus mirabilis Isolation from Hilla province. International J. of research studies in Biosciences (IJRSB), (2015); Vol.3 (10), pp: 85-89.
2-Abdulghani ST. The outcome of the Misuse of third Generation Cephalosporins in Fallujah City, West of Iraq. Al-Anbar Med. J., (2012); Vol.10 (2), pp: 46-50.
3-Adegbola RA, Old DC, Senior BW. The adhesins and fimbriae of Proteus mirabilis strains associated with high and low affinity for the urinary tract. J. Med. Microbiol. (1983); 16:427-431.
4-AL-Autbi DAK. Bacteriological study of some species of Enterobacteriaceae isolated from Hospital birth rooms in Baquba city. Thesis. (2013); Diyala University.
5-Al-Azawy AN, Al-Taai HRR, Al-Rajab IAM. Biological study of Proteus mirabilis isolated from different clinical sources in AL-Mqdadia city. Diyala J. for pure sci., (2015); Vol.11 (2), pp: 42-60. 6-Al-Bassam WW, Al- Kazaz A. The isolation and Characterization of Proteus mirabilis from different clinical Samples. J. of Biotechnology Research center (2013); Vol.7 (2) .
7-Al-Bayati NS. Bacteriological and epidemiological study of chronic superlative otitis media among primary school children in Tikrit city. M.Sc. Thesis, (2001); College of Medicine, Tikrit University.
8-Ali HH. Molecular study of some virulence factors of Proteus mirabilis isolated from urinary tract infection in Al-Qadisiyah Province. Thesis, (2015); College of Sciences, University of Al-Qadisiyah.
9-Ali HH, Yousif MG. Detection of some virulence factors genes of Proteus mirabilis that isolated from urinary tract infection. Research article. Inter. J. of Adv. Res. 3, Issue (2015); 1:156-163.
10-Al-jenahi MRA. Genetic study on isolated proteus mirabilis from urinary tract infection in children. Thesis, (2013); College of Education, Al-Qadisiya University.
11-Bahashwan SA, El-Shafey HM. Antimicrobial resistance patterns of Proteus¬ Isolates from Clinical Specimens. European Sci. J., (2013); Vol.9 (27). Taibah University, Al Madinah Al Munawara.
12-Baldo C, Rocha SPD. Virulence Factors of Uropathogenic Proteus Mirabilis - A Mini Review. Inter. J. of Scient. And Technol. Res. (2014);3: 24-27.
13-Barbour EK, Hajj ZG, Hamadeh S, Shaib HA, Farran MT, Araj G, Faroon O, Barbour KE, Jirjis F, Azhar E, Kumosani T, Harakeh S. Comparison of phenotypic and virulence genes characteristics in human and chicken isolates of Proteus mirabilis. Pathogens and Global Health, (2012); 106 (6):352-357.
14-Bartlett JMS, Stirling D (1998). PCR Protocols: Methods in Molecular Biology.2nd. Humana Press Inc. Totowa. NJ.
15-Coker C, Poore CA, Li X, Mobley HLT. Pathogenesis of Proteus mirabilis urinary tract infection. Microbes Infect. (2000); 2:1497-1505.
16-Filimon R, Iacob E. Incidence of nosocomial infection at the recovery clinic of Iasi hospital in 2004-2005. Rev. Med. Chir. Soc. Med. Iasi. (2007); 111(1): 255-257.
17-Forbes BA, Sahm DF, Weissfeld AS. Bailey and Scott's Diagnostic Microbiology. 12th ed. Missouri. Mosby Co.: (2007); 323-333.
18-Friedrich AW, Koch R, Bielasz ewska M, Zhang W, Karch H, Mathys W. Distribution of the Urease gene cluster among urea activity of enterohemorrhagic Escherichia coli OH157 isolated from humans. J. of Clin. Micr. (2005); 43(2)546-550.
19-Gangoue-Pieboji J, Koulla-Shiro S, Ngassam P et al. Antimicrobial activity against gram-negative bacilli from Yaounde Central Hospital, Cameroon. Afr. Health Sci., Vol. 6(4), (2006); pp: 232-235.
20-Guentzel MN (1996). Escherichia, Klebsiella, Enterobacter, Serratia, Citrobacter, and Proteus. In: Barron's Medical Microbiology (Barron's et al., eds.) (4th ed.). Univ of Texas Medical Branch.
21-Himpsl SD, Lockatell CV, Hebel JR, Johnson DE, Mobley HL. Identification of virulence determinants in uropathogenic Proteus mirabilis using signaturetaggedmutagenesis. J. Med. Microbiol. (2008); 57:1068-1078.
22-Jacobsen SM, Stickler DJ, Mobley HLT, ME, Shirtliff. Complicated Catheter-Associated Urinary Tract Infections Due to Escherichia coli and Proteus mirabilis. Clinical Microbiology Reviews, (2008); 21 (1): 26-59.
23-Li X, Lockatell CV, Johnson DE, Mobley HL. Identification of MrpI as the sole recombinase that regulates the phase variation of MR/P fimbria, a bladder colonization factor of uropathogenic Proteus mirabilis. Mol. Microbiol. (2002); 45:865-874.
24-Luzzaro FG, Lombardi M, Perlli R, Belloni G, Amicosante, A. Toniolo (2001). Antimicrobial susceptibility testing and ESBL production in clinical isolates of Proteus mirabilis: An evaluation with the phoenixâ„¢ automated microbiology system. Presesnted at the 10 1st General Meeting of the Amer. Soci. For Microbiology.
25-MacFaddin JF (2000). Biochemical tests for identification of medical bacteria. 3rd ed.Lippincott Williams and Wilkins, USA.
26-Manos J, Belas R. The genera Proteus, Providencia, and Morganella. In The prokaryotes. Vol. 6. 3rd ed. Edited by Dworkin, Springer, New York. (2006); pp. 245-269.
27-Mohammed GJ (2014). Phenotyping and molecular characterization of proteus vulgaris isolated from patients with urinary tract infections. Ph. D. Thesis, College of Medicine, Babylon University.
28-Morgenstein RM (2006). Proteus mirabilis swarming O-antigen, surface sensing, and the Rcs system. Microbiology and Molecular Genetics.
29-Naber KG, Schito GC, Botto H, Palou J, Mazzei T. Surveillance study in Europe and Brazil on clinical 1702 aspects and antimicrobial resistance epidemiology in females with cystitis (ARESC): implications for 1703 empiric therapy. Eur. Urol., (2008); 54 (12): 1164-1175.
30-Nielubowicz GR, Mobley HLT Host-pathogen interactions in urinarytract infection. Nat. Rev. Urol. (2010); 7(8): 430-441.
31-O’May GA, Jacobsen SM, Stickler DJ, Mobley HLT, Shirtliff ME. Complicated urinary tract infections due to catheters. The Role of Biofilms in Device-Related Infections. Book. (2008); 7142-Chap. 6.
32-Pearson MM, Sebaihia M, Churcher C, Quail MA, Seshasayee AS, Luscombe NM, Abdellah Z et al. Complete genome sequence of uropathogenic Proteus mirabilis, a master of both adherence and motility. J.Bacteriol. (2008); 190(11): 4027- 4037.
33-Pellegrino R, Scavone P, Umpiérrez A, Maskell DJ, Zunino P. Proteus mirabilis uroepithelial cell adhesin (UCA) fimbria plays a role in the colonization of the urinary tract, Pathogens and Disease, (2013); 67.104-107.
34-Ranjbar-Omid M, Arzanlou M, Amani M, Al-Hashem SKS, Mozafari NA, Doghaheh HP. Allicin from garlic inhibits the biofilm formation and urease activity of Proteus mirabilis in vitro. FEMS. Microbiol. Letters, (2015); 362 Issue 9.
35-Rozalski A, Torzewska A, Moryl M, Kwil I, Maszewska A, Ostrowska K, et al. Proteus sp.- an opportunistic bacterial pathogen -classification, swarming growth, clinical significance and virulence factors. Folia Biologica. ET. Oecologica. (2012); 8:1-17.
36-Stamm WE (1999). Urinary Tract Infections. In Clinical Infectious Disease: A practical approach, Root, K. (ed). P: 649-656. Oxford University Press, Inc, New York.
37-Takeuchi H, Yamamoto S, Terai A, Kurazono H, Takeda Y, Okada Y, Yoshida O. Detection of Proteus mirabilis urease gene in urinary calculi by polymerase. Chain reaction International journal of Urology, Vol. 3(3), (1996); pp: 202-206.
38-Thaler ER, Kennedy DW (2000). Cited in human, H.D.; Dupont, H.L.; Gradner, L.B. and Griffin, J.W. Textbook of internal medicine.4th ed. Wolters Kluwer Company. USA.
39-Untergasser A, Nijveen H, Rao X, Bisseling T, Geurts R, Leunissen JA. Primer3Plus, an enhanced web interface to Primer3. Nucleic Acids Res. 35(Web Server issue), (2007); pp: 71-74.
40-Uphoff TS, Welch RA. Nucleotide sequencing of the proteus mirabilis calcium–independent hemolysin genes(hpmA and hpmB) reveals sequence similarity with the serratia marcescens hemolysin genes (shlA and shlB). J. of bacterial. , Vol.173 (3), (1990); pp: 1206-1216.
41-Winokur PL, Canton R, Casellas J-M, Legakis N. Variations in the performance of strains expressing an extended-spectrum β-Lactamase phenotype and characterization of isolates from Europe, the Americas, and the Western Pacific region. Clinical Infections Diseases.Vol.32 (2), (2001); pp: 94-103.